Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

2.

Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient-Centred Measures of Perceived Dyspnea and Functional Disability.

Salaffi F, Carotti M, Di Donato E, Di Carlo M, Ceccarelli L, Giuseppetti G.

PLoS One. 2016 Mar 1;11(3):e0149240. doi: 10.1371/journal.pone.0149240. eCollection 2016.

3.

Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD).

Mittoo S, Frankel S, LeSage D, Strand V, Shah AA, Christopher-Stine L, Danoff S, Hummers LK, Swigris JJ, Huscher D, Christensen AM, Cenac SL, Erbil JK, Ferguson S, Garcia-Valladares I, Grewal HK, Orbai AM, Smith KC, Tran M, Bingham CO 3rd, Castelino FV, Fischer A, Saketkoo LA.

Curr Respir Med Rev. 2015 Jun;11(2):175-183.

4.

Cross-sectional study of soluble selectins, fractions of circulating microparticles and their relationship to lung and skin involvement in systemic sclerosis.

Iversen LV, Ullman S, Østergaard O, Nielsen CT, Halberg P, Karlsmark T, Heegaard NH, Jacobsen S.

BMC Musculoskelet Disord. 2015 Aug 12;16:191. doi: 10.1186/s12891-015-0653-8.

5.

Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis.

Wallace B, Kafaja S, Furst DE, Berrocal VJ, Merkel PA, Seibold JR, Mayes MD, Khanna D.

Rheumatology (Oxford). 2015 Aug;54(8):1369-79. doi: 10.1093/rheumatology/keu456. Epub 2015 Feb 9.

6.

Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study.

Fraticelli P, Gabrielli B, Pomponio G, Valentini G, Bosello S, Riboldi P, Gerosa M, Faggioli P, Giacomelli R, Del Papa N, Gerli R, Lunardi C, Bombardieri S, Malorni W, Corvetta A, Moroncini G, Gabrielli A; Imatinib in Scleroderma Italian Study Group.

Arthritis Res Ther. 2014 Jul 8;16(4):R144. doi: 10.1186/ar4606.

7.

Intensive aerobic and muscle endurance exercise in patients with systemic sclerosis: a pilot study.

Alexanderson H, Bergegård J, Björnådal L, Nordin A.

BMC Res Notes. 2014 Feb 7;7:86. doi: 10.1186/1756-0500-7-86.

8.

Feasibility and construct validity of PROMIS and "legacy" instruments in an academic scleroderma clinic.

Khanna D, Maranian P, Rothrock N, Cella D, Gershon R, Khanna PP, Spiegel B, Furst DE, Clements PJ, Bechtel A, Hays RD.

Value Health. 2012 Jan;15(1):128-34. doi: 10.1016/j.jval.2011.08.006. Epub 2011 Oct 22.

9.
10.

Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group.

Khanna D, Tseng CH, Farmani N, Steen V, Furst DE, Clements PJ, Roth MD, Goldin J, Elashoff R, Seibold JR, Saggar R, Tashkin DP.

Arthritis Rheum. 2011 Oct;63(10):3078-85. doi: 10.1002/art.30467.

11.

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.

Pidala J, Kurland B, Chai X, Majhail N, Weisdorf DJ, Pavletic S, Cutler C, Jacobsohn D, Palmer J, Arai S, Jagasia M, Lee SJ.

Blood. 2011 Apr 28;117(17):4651-7. doi: 10.1182/blood-2010-11-319509. Epub 2011 Feb 25.

12.

Valuation of scleroderma and psoriatic arthritis health states by the general public.

Khanna D, Frech T, Khanna PP, Kaplan RM, Eckman MH, Hays RD, Ginsburg SS, Leonard AC, Tsevat J.

Health Qual Life Outcomes. 2010 Oct 1;8:112. doi: 10.1186/1477-7525-8-112.

13.

Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design.

Khanna D, Seibold JR, Wells A, Distler O, Allanore Y, Denton C, Furst DE.

Curr Rheumatol Rev. 2010 May 1;6(2):138-144.

14.

Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease.

Swigris JJ, Yorke J, Sprunger DB, Swearingen C, Pincus T, du Bois RM, Brown KK, Fischer A.

Respir Med. 2010 Sep;104(9):1350-5. doi: 10.1016/j.rmed.2010.03.027. Epub 2010 May 14.

15.

Perceived functioning has ethnic-specific associations in systemic sclerosis: another dimension of personalized medicine.

McNearney TA, Hunnicutt SE, Fischbach M, Friedman AW, Aguilar M, Ahn CW, Reveille JD, Lisse JR, Baethge BA, Goel N, Mayes MD; GENISOS Study Group.

J Rheumatol. 2009 Dec;36(12):2724-32. doi: 10.3899/jrheum.090295. Epub 2009 Nov 16.

16.

Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung Study.

Khanna D, Tseng CH, Furst DE, Clements PJ, Elashoff R, Roth M, Elashoff D, Tashkin DP; for Scleroderma Lung Study Investigators.

Rheumatology (Oxford). 2009 Dec;48(12):1537-40. doi: 10.1093/rheumatology/kep284. Epub 2009 Sep 23.

17.

A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples.

Thombs BD, Bassel M, McGuire L, Smith MT, Hudson M, Haythornthwaite JA.

Rheumatology (Oxford). 2008 Oct;47(10):1559-63. doi: 10.1093/rheumatology/ken331. Epub 2008 Aug 13. Review.

18.

Complementary and alternative medicine use was associated with higher perceived physical and mental functioning in early systemic sclerosis.

Hunnicutt SE, Grady J, McNearney TA.

Explore (NY). 2008 Jul-Aug;4(4):259-63. doi: 10.1016/j.explore.2008.04.004.

19.

Health-related quality of life in emphysema.

Kaplan RM, Ries AL.

Proc Am Thorac Soc. 2008 May 1;5(4):561-6. doi: 10.1513/pats.200706-080ET. Review.

20.

Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study.

Khanna D, Furst DE, Hays RD, Park GS, Wong WK, Seibold JR, Mayes MD, White B, Wigley FF, Weisman M, Barr W, Moreland L, Medsger TA Jr, Steen VD, Martin RW, Collier D, Weinstein A, Lally EV, Varga J, Weiner SR, Andrews B, Abeles M, Clements PJ.

Ann Rheum Dis. 2006 Oct;65(10):1325-9. Epub 2006 Mar 15.

Supplemental Content

Support Center